The characterization of the translation initiation sites used by the most common native ERG and fusion variants reveals that the specific organization of the 5′ UTR region is one of the principal determinants of their biological activity and identifies an ATG in exon 4 as a putative target for antisense-based translation inhibition in prostate cancer. The gene discussed is ERG; the disease is prostate carcinoma.